Business Model: B2B
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
HEXI Capital focuses on investing in the most attractive assets in China, partnering with leading domestic companies with sustainable competitive positions in their markets as well as promising companies which comply with new economy, new service and new business models, in order to create best returns for their investors. Their major businesses include M&a;A investment business in the primary market (Shanghai Feiye Investment Management) and actively managed funds in the secondary market (Shanghai Hexi Investment).
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2017 | Unimed Biotech | Venture Round | 7.3M |
2/2017 | 3975.com | Series B | 2.9M |
3/2023 | Tonstarter | Seed Round | 1.5M |
4/2017 | ewan.cn | Series B | 1.5M |
1/2017 | MollyBox | Seed Round | - |
7/2022 | Fanzee Labs | Pre Seed Round | 0 |
7/2022 | Fanzee Labs | Pre Seed Round | 0 |
4/2017 | ewan.cn | Series B | 0 |
2/2017 | 3975.com | Series B | 0 |
2/2017 | Unimed Biotech | Venture Round | 0 |
1/2017 | MollyBox | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|